PanGen Biotech Inc Cash Flow Reinvestment Rate

Latest as of June 2025: 0.33x

PanGen Biotech Inc cash flow reinvestment rate. PanGen Biotech Inc (222110) has a Cash Flow Reinvestment Rate of 0.33x as of June 2025, reinvesting ₩1.07 Billion (capex ₩56.30 Million plus investments ₩1.01 Billion) from operating cash flow of ₩3.22 Billion. Explore how well can PanGen Biotech Inc service its debt to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.33x

(Capex + Investments) / Operating CF

Total Reinvested

₩1.07 Billion

Capex + Investments

Operating Cash Flow

₩3.22 Billion

KRW

Capital Expenditures

₩56.30 Million

KRW

Cash Flow Reinvestment Rate of PanGen Biotech Inc (2024–2024)

Cash flow reinvestment rate of PanGen Biotech Inc from 2024 to 2024. Historical reinvestment intensity for PanGen Biotech Inc across 1 annual periods. Explore PanGen Biotech Inc capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.

PanGen Biotech Inc Cash Flow Reinvestment Rate by Year (2024–2024)

PanGen Biotech Inc cash flow reinvestment rate by year from 2024 to 2024. Year-by-year capital reinvestment analysis for PanGen Biotech Inc. For the full cash flow conversion analysis, see cash efficiency ratio of PanGen Biotech Inc.

Year	Reinvestment Rate	Total Reinvested (KRW)	Operating CF	Capex	YoY Change
2024	3.59x	₩10.71 Billion	₩2.99 Billion	₩374.12 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow